3 July 2026 Addiction PBS Pharmaceuticals ‘Commercial decision’ to withdraw opioid addiction treatment
2 July 2026 PBS Pharmaceuticals TheHill PBS future of two leading MS therapies hangs on pricing decision
23 April 2026 Clinical PBS Pharmaceuticals Aussie-made hereditary angioedema therapy gains PBS listing
30 March 2026 Government PBS Public Health GLP-1s will come to the PBS: but not fast, and not for all… yet
4 December 2025 Neurology PBS Pharmaceuticals MS drug gets PBS listing as prevalence, economic burden soar
